CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
54%
Total
Publications
185
Total Open
Publications
99
Total
Citations
4.6K
Open Access
Percentage
54%
Total
Publications
185
Total Open
Publications
99
Total
Citations
4.6K
Breakdown
Publisher Open
19%
Both
27%
Other Platform Open
6%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 45%
37
Hybrid 31%
26
No Guarantees 24%
20
Other Platform Open
Domain 83%
49
Institution 24%
14
Other Internet 19%
11
Public 3%
2
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 49 |
DOI | Other Internet | 7 |
Unknown Repository | Other Internet | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
Europe PMC | Domain | 4 |
University of Michigan - Deep Blue | Institution | 3 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |
University of Milano-Bicocca - BOA | Institution | 1 |
University of Lisbon - Repositório da Universidade de Lisboa | Institution | 1 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 1 |